(Q44512972)

3 December 2017

Antiproliferative effect of Ca2+ channel blockers on human epidermoid carcinoma A431 cells (English)

1 reference

3 December 2017

Junko Yoshida

1

1 reference

3 December 2017

Takaharu Ishibashi

series ordinal

2

1 reference

3 December 2017

Matomo Nishio

series ordinal

3

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

European Journal of Pharmacology

3 December 2017

1 reference

3 December 2017

472

1 reference

3 December 2017

1-2

1 reference

3 December 2017

23-31

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

3 December 2017

1 reference

Suppression of human tumor cell proliferation through mitochondrial targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Mitochondrial control of calcium-channel gating: a mechanism for sustained signaling and transcriptional activation in T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Calcium channel antagonists inhibit growth of subcutaneous xenograft meningiomas in nude mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

In vitro growth inhibition of growth factor-stimulated meningioma cells by calcium channel antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Calcium channel antagonist effect on in vitro meningioma signal transduction pathways after growth factor stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Plasma membrane calcium channels in human carcinoma A431 cells are functionally coupled to inositol 1,4,5-trisphosphate receptor-phosphatidylinositol 4,5-bisphosphate complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Activation of calcium entry in human carcinoma A431 cells by store depletion and phospholipase C- dependent mechanisms converge on ICRAC-like calcium channels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Low-conductance high selective inositol (1,4,5)-trisphosphate activated Ca2+ channels in plasma membrane of A431 carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Miniature Ca2+ channels in excised plasma-membrane patches: activation by IP3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Inhibition of cell growth and intracellular Ca2+ mobilization in human brain tumor cells by Ca2+ channel antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Calcium channels activated by depletion of internal calcium stores in A431 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Smooth muscle cell cycle and proliferation. Relationship between calcium influx and sarco-endoplasmic reticulum Ca2+ATPase regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Calcium antagonists and vascular smooth muscle cell reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Involvement of Ca2+-induced Ca2+ release in the biphasic Ca2+ response evoked by readdition of Ca2+ to the medium after UTP-induced store depletion in A431 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Store depletion and calcium influx

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Verapamil inhibits proliferation of LNCaP human prostate cancer cells influencing K+ channel gating.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Vascular smooth muscle cell migration, atherosclerosis, and calcium channel blockers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Calcium antagonists and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Intracellular Ca2+ pool content is linked to control of cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Amlodipine inhibits thapsigargin-sensitive CA(2+) stores in thrombin-stimulated vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Amlodipine inhibition of serum-, thrombin-, or fibroblast growth factor-induced vascular smooth-muscle cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Dual mechanism of action of amlodipine in human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Calcium channels, stores, and oscillations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Calcium channel blockers and coronary atherosclerosis: from the rabbit to the real world

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

Widening potential for Ca2+ antagonists: non-L-type Ca2+ channel interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2803%2901831-4

10.1016/S0014-2999(03)01831-4

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference